Energy needs after head and neck cancer surgery with free flap reconstruction

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with head and neck cancer undergoing free flap reconstruction at Tel Aviv Sourasky Medical Center will have energy expenditure measured with indirect calorimetry and body composition assessed non-invasively, along with a short food-intake questionnaire and routine clinical data collection. The study will compare pre- and post-operative energy needs and explore associations with recovery outcomes and complications. It uses observational, nutritional assessments to better understand perioperative nutrition requirements. No experimental treatments are given beyond standard nutritional assessments; data are gathered from medical records and direct measurements. Participation depends on consent and availability of required measurements and follow-up information.

Why it matters

Who can join: the full rules

Inclusion Criteria

* Adults aged 18 years or older.
* Diagnosis of head and neck cancer.
* Scheduled to undergo or have undergone free flap reconstruction surgery at Tel Aviv Sourasky Medical Center.
* Availability of indirect calorimetry measurements, nutritional data, postoperative -complications data, and follow-up information.
* Ability and willingness to provide informed consent.

Exclusion Criteria:

* Age younger than 18 years.
* Pregnant women.
* Individuals unable to provide informed consent.
* Vulnerable populations as defined by local regulations.
* Death before completion of study assessments.

Where it's running

• Ichilov Hospital
  Tel Aviv, Israel Recruiting

Study contacts

• Study coordinator: Anton Waeshavsky MD
• Email: anton.warshavsky@gmail.com
• Phone: +972505628629

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Phenotype-based Pain Guidance for Head and Neck Cancer-Related Pain (pilot)

  This pilot test sees if tailoring pain treatment to a patient’s pain type can reduce head and neck cancer pain in adults who haven’t started cancer treatment yet.

  Recruiting Phase 2 Shaukat Khanum Memorial Cancer Hospital & Research Centre · Lahore, Punjab Province · NCT07919444

• Airway ultrasound in head and neck cancer patients

  This observational study tests whether neck ultrasound measurements of the airway match CT measurements in adults with maxillofacial cancer undergoing surgery with anesthesia.

  Recruiting at 2 sites University Hospital Dubrava · Zagreb, City of Zagreb and 1 other locations · NCT07910149

• Safe use of metformin and naproxen to help prevent cancer in people with Fanconi anemia

  This study tests whether metformin and naproxen can lower the chance of cancer developing in adults with Fanconi anemia.

  Recruiting at 2 sites Phase 1 Rockefeller University · Minneapolis, Minnesota and 1 other locations · NCT07901959

• Iparomlimab and Tuvonralimab With Cetuximab Before Surgery in Resectable Oral Cancer

  In this phase 2 study, patients with locally advanced, resectable oral squamous cell carcinoma will receive a combination of iparomlimab, tuvonralimab, and cetuximab before surgery to see if the treatment is safe and can shrink tumors.

  Recruiting Phase 2 Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University · Shanghai, Shanghai Municipality · NCT07882888

• SumMET: Targeted radioligand therapy for c-MET–positive solid tumors

  This first‑in‑human study tests the safety and potential effectiveness of a radioligand therapy called [225Ac]Ac-FL-261 in adults with advanced or metastatic solid tumors that overexpress c-MET.

  Recruiting at 2 sites Phase 1/2 Full-Life Technologies UK Limited · Minneapolis, Minnesota and 1 other locations · NCT07873450

• Using Silverlon for head and neck patients with tracheostomies

  This early-phase study tests whether Silverlon dressings can prevent severe skin reactions under tracheostomy collars in adults with head and neck cancer.

  Recruiting Phase 1 State University of New York - Upstate Medical University · Syracuse, New York · NCT07856732

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.